English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment Journal article
Huang Shigao, Xing Fuqiang, Dai Yeneng, Zhang Zhiming, Zhou Guangyu, Yang Shuo, Liu Yu-Cheng, Yuan Zhen, Luo Kathy Qian, Ying Tianlei, Chu Dafeng, Liu Tzu-Ming, Deng Chu-Xia, Zhao Qi. Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment[J]. Journal of Controlled Release, 2023, 362, 524-535.
Authors:  Huang Shigao;  Xing Fuqiang;  Dai Yeneng;  Zhang Zhiming;  Zhou Guangyu; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:10.5/10.6 | Submit date：2023/09/28
Car-nk Cells  Tumor Microenvironment  Three-dimensional Slice Culture  Photothermal Therapy  Intravital Two-photon Imaging  
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:  Zhou,Jing Bo;  Tang,Dongyang;  He,Lin;  Lin,Shiqi;  Lei,Josh Haipeng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.1/9.0 | Submit date：2023/08/03
Bortezomib (Pubchem Cid: 387447)  Cepharanthine (Pubchem Cid: 10206)  Docetaxel (Taxotere) (Pubchem Cid: 11970251)  Drug Combination Therapy  Flunarizine Dihydrochloride (Pubchem Cid: 5282407)  Lapatinib Ditosylate (Pubchem Cid: 9941095)  Machine Learning  Pazopanib Hydrochloride (Pubchem Cid: 11525740)  Potential Combination Biomarkers  Tamoxifen Citrate (Pubchem Cid: 2733525)  Three-dimensional Tumor Slice Culture  Vatalanib (Pubchem Cid: 151194)  Vincristine (Pubchem Cid: 5978)  Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)  
Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform Journal article
Xing, Fuqiang, Liu, Yu Cheng, Huang, Shigao, Lyu, Xueying, Su, Sek Man, Chan, Un In, Wu, Pei Chun, Yan, Yinghan, Ai, Nana, Li, Jianjie, Zhao, Ming, Rajendran, Barani Kumar, Liu, Jianlin, Shao, Fangyuan, Sun, Heng, Choi, Tak Kan, Zhu, Wenli, Luo, Guanghui, Liu, Shuiming, Xu, De Li, Chan, Kin Long, Zhao, Qi, Miao, Kai, Luo, Kathy Qian, Ge, Wei, Xu, Xiaoling, Wang, Guanyu, Liu, Tzu Ming, Deng, Chu Xia. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform[J]. Theranostics, 2021, 11(19), 9415-9430.
Authors:  Xing, Fuqiang;  Liu, Yu Cheng;  Huang, Shigao;  Lyu, Xueying;  Su, Sek Man; et al.
Adobe PDF | Favorite | TC[WOS]:16 TC[Scopus]:18  IF:12.4/12.0 | Submit date：2021/11/30
3d Tumor Slice Culture  Apoptosis  Fret Technique  Label-free  Personalized Medicine  
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy Journal article
Lei, Josh Haipeng, Lee, Mi Hye, Miao, Kai, Huang, Zebin, Yao, Zhicheng, Zhang, Aiping, Xu, Jun, Zhao, Ming, Huang, Zenan, Zhang, Xin, Chen, Si, Jiaying, N. G., Feng, Yuzhao, Xing, Fuqiang, Chen, Ping, Sun, Heng, Chen, Qiang, Xiang, Tingxiu, Chen, Lin, Xu, Xiaoling, Deng, Chu Xia. Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy[J]. Advanced Science, 2021, 8(21), 2100974.
Authors:  Lei, Josh Haipeng;  Lee, Mi Hye;  Miao, Kai;  Huang, Zebin;  Yao, Zhicheng; et al.
Favorite | TC[WOS]:23 TC[Scopus]:17  IF:14.3/16.3 | Submit date：2021/11/30
Brca1  Breast Cancer  Fgfr2 Inhibitor  Fgfr2-s252w  Tumor Slice Culture